The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells. 1989

P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
Department of Pathology, National Research Institute for Family Planning, Beijing, China.

The effect of three different intrauterine devices on the DNA content in human endometrial cells has been studied in 29 women before and after the insertion of an IUD; a stainless steel ring (9 subjects), Copper-T220 (11 subjects) and a medicated IUD releasing levonorgestrel at a rate of 2 micrograms/day (9 subjects). The material was grouped into "bleeders" (having more than 8 days of bleeding and spotting per month) and "non-bleeders" (having less than 8 days of bleeding and spotting per month). The DNA content was assessed on isolated endometrial cells smeared from thin biopsies and the amount of DNA per cell nucleus was measured by means of a Feulgen microspectrophotometric method. No significant difference was found between the "bleeders" and the "non-bleeders" as to the DNA content. Nevertheless, when the total number of subjects were pooled together, a significant increase in the DNA content was found in the post-insertion specimens in the groups of women using the SS and the T-Cu IUDs. Furthermore, a significant decrease in the DNA content was also found when the specimens obtained after the insertion of the LNG IUD were compared with those obtained after 24 months' use of the stainless steel ring and the Copper-T220 device (p less than 0.01 and p less than 0.002, respectively). It is concluded that the insertion of an inert IUD or an T-Cu IUD, induces significant alterations in the DNA content of the human endometrium adjacent to the device, whereas the use of the LNG device does not significantly modify the DNA synthesis when used for 3-10 months. No correlation was found between the DNA content per cell and the number of days of bleeding and spotting.

UI MeSH Term Description Entries
D007434 Intrauterine Devices Contraceptive devices placed high in the uterine fundus. Contraceptive Devices, Intrauterine,Contraceptive IUD,Contraceptive IUDs,IUD, Unmedicated,Unmedicated IUDs,Contraceptive Device, Intrauterine,Device, Intrauterine,Device, Intrauterine Contraceptive,Devices, Intrauterine,Devices, Intrauterine Contraceptive,IUD, Contraceptive,IUDs, Contraceptive,Intrauterine Contraceptive Device,Intrauterine Contraceptive Devices,Intrauterine Device,Unmedicated IUD
D007435 Intrauterine Devices, Copper Intrauterine contraceptive devices that depend on the release of metallic copper. Copper Intrauterine Devices,Copper-Releasing IUDs,IUD, Copper Releasing,Copper Intrauterine Device,Copper Releasing IUD,Copper-Releasing IUD,Device, Copper Intrauterine,Devices, Copper Intrauterine,IUD, Copper-Releasing,IUDs, Copper-Releasing,Intrauterine Device, Copper
D007436 Intrauterine Devices, Medicated Intrauterine devices that release contraceptive agents. Hormone-Releasing IUDs,IUD, Hormone Releasing,Intrauterine Devices, Hormone-Releasing,Intrauterine Devices, Progesterone-Releasing,Medicated Intrauterine Devices,Device, Hormone-Releasing Intrauterine,Device, Medicated Intrauterine,Device, Progesterone-Releasing Intrauterine,Devices, Hormone-Releasing Intrauterine,Devices, Medicated Intrauterine,Devices, Progesterone-Releasing Intrauterine,Hormone Releasing IUD,Hormone-Releasing IUD,Hormone-Releasing Intrauterine Device,Hormone-Releasing Intrauterine Devices,IUD, Hormone-Releasing,IUDs, Hormone-Releasing,Intrauterine Device, Hormone-Releasing,Intrauterine Device, Medicated,Intrauterine Device, Progesterone-Releasing,Intrauterine Devices, Hormone Releasing,Intrauterine Devices, Progesterone Releasing,Medicated Intrauterine Device,Progesterone-Releasing Intrauterine Device,Progesterone-Releasing Intrauterine Devices
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D009644 Norgestrel A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-,DL-Norgestrel,Neogest,Ovrette,Postinor,Wy-3707,DL Norgestrel,Wy 3707,Wy3707
D003592 Cytophotometry A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope. Microfluorometry,Cytophotometries,Microfluorometries
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
January 1972, Acta cytologica,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
December 1965, American journal of obstetrics and gynecology,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
January 1977, Acta cytologica,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
April 2013, The journal of family planning and reproductive health care,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
June 1998, Advances in contraception : the official journal of the Society for the Advancement of Contraception,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
October 1982, Akusherstvo i ginekologiia,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
August 1994, Zhonghua fu chan ke za zhi,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
February 1997, Zhonghua fu chan ke za zhi,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
June 1991, Obstetrics and gynecology,
P D Zhu, and H Z Luo, and J Cheng, and R H Xu, and Y F Liu, and W M Zheng, and G Y Song, and J H Chen, and Z H Zhou, and Y M Wu
February 1991, Obstetrics and gynecology,
Copied contents to your clipboard!